Stephen S. Yoder
About Stephen S. Yoder
Stephen S. Yoder: President and Chief Executive Officer at Pieris Pharmaceuticals
Stephen S. Yoder has been serving as the President and Chief Executive Officer of Pieris Pharmaceuticals since January 2010. In this role, he oversees the strategic direction and operations of the company, aiming to advance its clinical-stage biopharmaceutical endeavors. With over a decade in this leadership position, Yoder brings a wealth of experience and knowledge in biotech and pharmaceuticals to Pieris.
Stephen S. Yoder’s Role at MorphoSys AG
Before joining Pieris Pharmaceuticals, Stephen S. Yoder led the intellectual property and legal departments at MorphoSys AG as General Counsel from July 2003 to December 2009. His responsibilities included managing legal affairs and protecting the company's intellectual property assets, which is crucial for a biopharmaceutical company specializing in innovative therapeutic solutions.
Stephen S. Yoder’s Legal Career in Washington D.C.
Prior to his tenure at MorphoSys AG, Stephen S. Yoder worked at several law firms in Washington, D.C. from September 1999 to June 2003. In these roles, he specialized in life sciences intellectual property, offering legal expertise that was essential for clients in the biotechnology and pharmaceutical sectors. His background in intellectual property law provided a solid foundation for his subsequent roles in the biotech industry.
Stephen S. Yoder’s Education in Molecular Biology and Law
Stephen S. Yoder holds degrees in molecular biology and Spanish from Grove City College. Further advancing his education, he earned a Juris Doctorate, with honors, from The George Washington University Law School. This combination of scientific and legal training uniquely positions Yoder with a deep understanding of both the technical and regulatory aspects of the biopharmaceutical industry.